New technique improves bone regeneration in rats

Although bones have the ability to regenerate and repair themselves, they are generally unable to do so when the injury is larger than a small break or chip. In a study just published in Inflammation and Regeneration, Japanese researchers have developed a technique for improving bone regeneration over large areas in rats-;and their findings may translate well to clinical settings.

As most of us know from experience, bones can repair themselves after a minor break or fracture, leaving us as good as new. Unfortunately, after a larger injury-;or if a lot of bone needs to be removed because of something like a tumor-;bones often don't heal well. Although there are many different ways to improve bone repair over larger areas in animal models, very few techniques translate well into the clinic.

A research team from Tokyo Medical and Dental University (TMDU) decided to tackle this challenge using vascular endothelial growth factor (VEGF), which improves regeneration of the blood circulatory system, and Runt-related transcription factor 2 (Runx2), which is important for bone regeneration.

We had already used these two factors to improve bone regeneration in mice in a previous study. But we injected DNA, which can insert itself into the body's genetic information, rather than RNA, which cannot; this meant that our findings had little clinical relevance because of the risks involved."

Keiji Itaka, senior author of the study

In their new study, the researchers used messenger RNA encoding VEGF and Runx2. They first demonstrated that the combination of these two RNAs led to a better regenerative response in bone cells than each RNA alone. Next, they injected the RNA combination into rats with large jawbone lesions. After three weekly injections, the jawbones of these mice were almost completely healed, unlike those of control mice. Importantly, their technique may have similar results in a clinical setting and is likely to be safe for use in humans.

"Our technique is especially promising for clinical use because of the coating that we used for the VEGF and Runx2 RNA," explains Maorui Zhang, lead author of the study. "Many previous studies have used lipid nanoparticles, but this coating leads to inflammation, limiting its clinical use. We used a coating that we had developed previously, known as polyplex nanomicelles, which leads to very little inflammation."

Given that large bone injuries can be difficult to repair in the clinic, the findings of this study bring new hope to patients. The use of combinations of RNA coated in polyplex nanomicelles is potentially an effective, low-risk technique for improving bone repair in humans and has many promising clinical applications.